Article ID Journal Published Year Pages File Type
3999660 Urologic Oncology: Seminars and Original Investigations 2015 8 Pages PDF
Abstract
UBPGLs typically present with a noradrenergic phenotype and are frequently associated with underlying germline mutations. Patients presenting with these rare neuroendocrine tumors should be screened for these mutations. In addition, patients with UBPGLs should be followed up closely for metastatic development regardless of genetic background, as almost half of the patients in this series presented with metastatic disease and less than half of them had SDHB mutations.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , , , ,